Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Veracyte, MaviDx Ink Agreement to Develop COVID-19 Assay

Veracyte, MaviDx Ink Agreement to Develop COVID-19 Assay

Jul 29, 2020
|
staff reporter

NEW YORK – South San Francisco-based Veracyte and MaviDx said on Wednesday they have signed an agreement for MaviDx to develop ultra-high throughput genomic testing for SARS-CoV-2 on Veracyte's nCounter diagnostic platform.

As part of the collaboration, Miami-based MaviDx will develop, validate, secure regulatory approvals for, and commercialize SARS-CoV-2 and other infectious disease tests, including for influenza, on the nCounter system.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

EUA Now Sought

Pfizer and BioNTech announce they are seeking FDA authorization for their candidate SARS-CoV-2 vaccine.

Former Minister's Paper Retracted

Science has retracted a 2007 paper from a former Dutch minister and his colleagues, according to Retraction Watch.

Mink Cull and a Prime Minister

The New York Times reports that a plan to cull minks in Denmark to prevent the spread of a new SARS-CoV-2 strain led to calls for the prime minister's resignation.

Science Presents Prize Winner for Single-Cell Genomic Methods, Study of Erlotinib Insensitivity in Triple-Negative Breast Cancer

In Science this week: winner of the Science & SciLifeLab Prize for Young Scientists, and more.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

What's Popular?

In Infectious Disease

  1. Illumina, IDbyDNA Flesh Out Sequencing-Based Respiratory Tests

    Premium

  2. FDA Grants Emergency Use Authorization to First At-Home COVID-19 Test From Lucira Health

  3. Hologic Receives Additional FDA Approval for Diagnostic Use of HIV-1 Viral Load Test

  4. PathoFinder Obtains CE Mark for Two Multiplex SARS-CoV-2 MDx Tests

  5. Qiagen Obtains CE Mark for Multiplex Respiratory Infection Test, Saliva-Based SARS-CoV-2 Assay

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.